Bringing together established leaders to realize the full potential of inhibiting Gasdermin D for patients.
Discovering therapeutics in a new field is no easy task, but Quench Bio is well suited to face this challenge head-on. We’ve assembled a world-class team of biopharma veterans with over 100 collective years of experience as well as scientists with deep expertise in inflammation, cell death and gasdermin biology. In addition, we’ve built a renowned board and advisory team who work closely with us as we lead the charge to target gasdermins. Together, we can make a meaningful difference for patients with a range of severe inflammatory diseases.